109 related articles for article (PubMed ID: 563206)
1. [Thromboembolic disease of long standing with hyperfibrinogenemia. Treatment with heparin, magnesium and anti-inflammatory agent].
Cristau P; Hainaut J; Molinie C; Essioux H; Pariente A; Florent C; Laverdant C
Ann Med Interne (Paris); 1977 Nov; 128(11):887-94. PubMed ID: 563206
[No Abstract] [Full Text] [Related]
2. [Esfar in an ENT department].
Traissac L; Pasquet J
Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):177-9. PubMed ID: 1034331
[No Abstract] [Full Text] [Related]
3. Use of a new anti-inflammatory agent, bucloxic acid, in the treatment of chronic glomerular nephropathies.
Lagrue G; Masbernard A; Giudicelli C; Hirbec G
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1434-9. PubMed ID: 4614821
[No Abstract] [Full Text] [Related]
4. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
Sessner HH; Brockhaus W; Kunzmann G; Stingl J
Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
[No Abstract] [Full Text] [Related]
5. [Criteria of treatment in the intravascular coagulation syndrome in children].
Chipail A; Schneer JH
Pediatria (Bucur); 1971; 20(5):457-62. PubMed ID: 5166666
[No Abstract] [Full Text] [Related]
6. [Heparin treatment of thromboembolic complications].
Samama M; Kher A; Horellou MH; Conard J
Agressologie; 1983 Nov; 24(10):495-500. PubMed ID: 6367509
[No Abstract] [Full Text] [Related]
7. [Evaluation of heparin therapy: sensitivity of the various methods].
Merino J; González-Boullosa R; Benet I; García-Conde J
Rev Clin Esp; 1978 Oct; 151(2):107-11. PubMed ID: 740979
[No Abstract] [Full Text] [Related]
8. [Importance of heparin in infants with consumption coagulation disease caused by septicemia].
de Aquino-Jaso ME; Olvera-Hidalgo C; Ramírez JI
Bol Med Hosp Infant Mex; 1974; 31(1):73-84. PubMed ID: 4433389
[No Abstract] [Full Text] [Related]
9. [Heparin therapy in the disseminated intravascular coagulation syndrome. Considerations on 2 cases].
Cutcudache C; Pavelescu I; Brăilescu G; Bălan A; Boldescu G; Lachi D
Med Interna (Bucur); 1971 Jun; 23(6):729-40. PubMed ID: 5565661
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of a new anti-inflammatory agent in the field of otorhinolaryngology].
Roux O
JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Sep; 24(7):545-7. PubMed ID: 129512
[No Abstract] [Full Text] [Related]
11. [Salivary gland involvement during various anti-inflammatory treatments. Apropos of 2 cases].
Verliac F; Calamy G; Palangié A; Bastin R
Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):561-5. PubMed ID: 1034456
[No Abstract] [Full Text] [Related]
12. [A new anti-inflammatory agent: calcium bucloxate in pediatrics].
Debray H; Galland A
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1440-2. PubMed ID: 4548650
[No Abstract] [Full Text] [Related]
13. [Biological surveillance during a test of 804 CB in internal medicine. 120 observations].
Gallais H; Casanova P
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1442-4. PubMed ID: 4480073
[No Abstract] [Full Text] [Related]
14. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
Louyot P; Tamisier JN; Pourel J
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1428-31. PubMed ID: 4614820
[No Abstract] [Full Text] [Related]
15. Heparin treatment of intravascular coagulation accompanying hemolytic transfusion reactions.
Rock RC; Bove JR; Nemerson Y
Anesth Analg; 1970; 49(2):231-5. PubMed ID: 4996107
[No Abstract] [Full Text] [Related]
16. [Results of clinical trials of calcium bucloxate (804 CB) in rheumatology].
de Sèze S; Dryll A; Dreiser R
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1425-8. PubMed ID: 4614819
[No Abstract] [Full Text] [Related]
17. [Resuscitation of patients with high risk of hemorrhage and thromboembolism. Biological supervision. Indications of controlled heparin therapy].
Boneu B; Cathala B; Jorda MF; Bierme R; Lareng L
Nouv Presse Med; 1972 Jan; 1(1):29-32. PubMed ID: 5061187
[No Abstract] [Full Text] [Related]
18. Sources of error in heparin therapy of thromboembolic disease.
Hattersley PG; Mitsuoka JC; King JH
Arch Intern Med; 1980 Sep; 140(9):1173-5. PubMed ID: 7406615
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of 804 CB and phenylbutazone. Double blind test of venous and arterial pathology].
Beurey J; Weber M; Toussain P; Jacob M
Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1432-4. PubMed ID: 4480072
[No Abstract] [Full Text] [Related]
20. [Diagnosis of acute acquired defects of coagulation and their therapy (author's transl)].
Göbel EA
Anaesthesist; 1976 Sep; 25(9):449-53. PubMed ID: 970600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
